source
- Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effectsA new analysis of patients who took part in clinical trials for Kite Pharma’s CAR-T cell therapy Yescarta has revealed genetic signatures of toxicity risk, potentially providing a path forward for…Fierce Biotech · 5d ago↗ source
- A new, separate outbreak of the diarrhea-causing parasiteA win for peptide proponents, autism advisory committees clash, and more health news from Morning RoundsSTAT · 5d ago↗ source
- STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pillMerck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started quickly.STAT